NOVN - ノバン (Novan Inc.)

NOVNのニュース

   Novan to Report Second Quarter 2021 Financial Results on August 12, 2021  2021/08/05 12:05:00 Intrado Digital Media
Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET
   Perspiring Stock: Netflix, Inc. (NASDAQ:NFLX), Novan, Inc. (NASDAQ:NOVN)  2021/08/01 21:18:16 Stock Equity
Netflix, Inc. (NFLX) with the stream of 0.65% also noticed, India Novan, Inc. (NOVN) encountered a rapid change of 5.35% in the last hour of trading session. Netflix, Inc. (NASDAQ:NFLX) The post Perspiring Stock: Netflix, Inc. (NASDAQ:NFLX), Novan, Inc. (NASDAQ:NOVN) appeared first on Stocks Equity .
   Novan completes patient visits in late-stage SB206 skin infection trial  2021/07/28 12:33:14 Seeking Alpha
   Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum  2021/07/28 12:05:00 Intrado Digital Media
Company previously reported positive topline efficacy and favorable safety data at Week 12 from B-SIMPLE4 in June 2021, with primary endpoint achieving statistical significance with p-value less than 0.0001 and no serious adverse events related to treatment with SB206
   Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape  2021/07/27 00:00:00 Benzinga
Los Angeles, July 26, 2021 (GLOBE NEWSWIRE) -- Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape With a handful of novel therapies emerging this year, pharmaceuticals have a lot more potential to explore in the field of Genital Warts. DelveInsight''s Genital Warts Pipeline Insight, 2021'' report offers an exhaustive global coverage of the available marketed therapies, Genital Warts pipeline therapies in different phases of clinical development, key companies working to advance the pipeline space, and future growth potential of the Genital Warts pipeline domain. Some of the major pointers taken from the Genital Warts Pipeline report: DelveInsight''s analysis presents Genital Warts Pipeline with 6+ active players in the domain investigating 6+ pipeline therapies . Major companies such as pHion Therapeutics, Orgenesis, KinoPharma, Novan, Cassiopeia, Innovax, Verrica Pharmaceuticals and others are developing potential drug candidates to improve the Genital Warts treatment scenario.
   Novan to Report Second Quarter 2021 Financial Results on August 12, 2021  2021/08/05 12:05:00 Intrado Digital Media
Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ET
   Perspiring Stock: Netflix, Inc. (NASDAQ:NFLX), Novan, Inc. (NASDAQ:NOVN)  2021/08/01 21:18:16 Stock Equity
Netflix, Inc. (NFLX) with the stream of 0.65% also noticed, India Novan, Inc. (NOVN) encountered a rapid change of 5.35% in the last hour of trading session. Netflix, Inc. (NASDAQ:NFLX) The post Perspiring Stock: Netflix, Inc. (NASDAQ:NFLX), Novan, Inc. (NASDAQ:NOVN) appeared first on Stocks Equity .
   Novan completes patient visits in late-stage SB206 skin infection trial  2021/07/28 12:33:14 Seeking Alpha
   Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum  2021/07/28 12:05:00 Intrado Digital Media
Company previously reported positive topline efficacy and favorable safety data at Week 12 from B-SIMPLE4 in June 2021, with primary endpoint achieving statistical significance with p-value less than 0.0001 and no serious adverse events related to treatment with SB206
   Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape  2021/07/27 00:00:00 Benzinga
Los Angeles, July 26, 2021 (GLOBE NEWSWIRE) -- Genital Warts Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companies, Growth Prospects and Future Genital Warts Pipeline Landscape With a handful of novel therapies emerging this year, pharmaceuticals have a lot more potential to explore in the field of Genital Warts. DelveInsight''s Genital Warts Pipeline Insight, 2021'' report offers an exhaustive global coverage of the available marketed therapies, Genital Warts pipeline therapies in different phases of clinical development, key companies working to advance the pipeline space, and future growth potential of the Genital Warts pipeline domain. Some of the major pointers taken from the Genital Warts Pipeline report: DelveInsight''s analysis presents Genital Warts Pipeline with 6+ active players in the domain investigating 6+ pipeline therapies . Major companies such as pHion Therapeutics, Orgenesis, KinoPharma, Novan, Cassiopeia, Innovax, Verrica Pharmaceuticals and others are developing potential drug candidates to improve the Genital Warts treatment scenario.
   Novartis-Aktie: Rückschlag  2021/06/12 20:00:18 BORSE ONLINE
Der Schweizer Pharmakonzern Novartis hat mehrere klinische Studien zu seinem Augenmedikament Beovu abgebrochen. Grund seien höhere Raten von intraokularen Entzündungen als bei der Vergleichstherapie. Von Sven Parplies, Euro am Sonntag
   Biosimilar of Remicade Market Future Trends, Revenue Growth, Profitability & Leading Players| Key players- Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), etc.  2021/06/12 09:00:41 Jumbo News
Biosimilar of Remicade Market to 2027: Deep Analysis The report offers a complete research study of the global Biosimilar of Remicade Market that includes accurate forecasts and analysis at global, regional, and country levels. It provides a comprehensive view of the global Biosimilar of Remicade Market and detailed value chain analysis to help players to []
   Glaucoma Treatment Market Current Status, In-depth Analysis and Forecast 2021-2026 : Novartis AG, Allergan, Merck & Co. Inc., Akorn Inc.  2021/06/12 02:30:51 Jumbo News
Pixion Market Research new study, Glaucoma Treatment Market Report 2021 provides an analytical assessment of the primary challenges faced by this market currently and in the coming years. The insights of the subject matter presented in the report will help market players in understanding the problems they may face while operating in this market over []
   The Buzz Show: Novan, Inc. (NASDAQ: NOVN) Surges Upon Announcement of Positive Preclinical Data  2021/06/11 20:42:29 Financial Buzz
FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Novan, Inc. Surges Upon Announcement of Positive Preclinical Data Novan, Inc. (NASDAQ: NOVN) surged over 60% in premarket trading after the company announced positive topline efficacy and safety results for the B-SIMPLE4 pivotal Phase 3 clinical study of SB206 There are currently no U.S. The post The Buzz Show: Novan, Inc. (NASDAQ: NOVN) Surges Upon Announcement of Positive Preclinical Data first appeared on Financial Buzz .
   FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer  2021/06/11 18:07:09 US Food and Drug Administration
FDA granted accelerated approval to capmatinib (TABRECTATM, Novartis) for adult patients with metastatic non-small cell lung cancer whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.

calendar